Literature DB >> 32098707

Disparities in the appropriateness of medication use: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population-based cohort study.

Motiur Rahman1, George Howard2, Jingjing Qian3, Kimberly Garza3, Ash Abebe4, Richard Hansen5.   

Abstract

BACKGROUND: Prior work has identified disparities in the quality and outcomes of healthcare across socioeconomic subgroups. Medication use may be subject to similar disparities.
OBJECTIVE: To assess the association between demographic and socioeconomic factors (gender, age, race, income, education, and rural or urban residence) and appropriateness of medication use.
METHODS: US adults aged ≥45 years (n = 26,798) from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study were included in the analyses, of which 13,623 participants aged ≥65 years (recruited 2003-2007). Potentially inappropriate medication (PIM) use in older adults and drug-drug interactions (DDIs) were identified through 2015 Beers Criteria and clinically significant drug interactions list by Ament et al., respectively as measures of medication appropriateness. Multivariable logistic regression was used to assess the association of disparity parameters with PIM use and DDIs. Interactions between race and other disparity variables were investigated.
RESULTS: Approximately 87% of the participants aged ≥65 years used at least one drug listed in the Beers Criteria, and 3.8% of all participants used two or more drugs with DDIs. Significant gender-race interaction across prescription-only drug users revealed that white females compared with white males (OR = 1.33, 95% CI 1.20-1.48) and black males compared with white males (OR = 1.60, 95% CI 1.41-1.82) were more likely to receive PIM. Individuals with lower income and education also were more likely to use PIM in this sub-group. Females were less likely than males (female vs. male: OR = 0.55, 95% CI 0.48-0.63) and individuals resided in small rural areas as opposed to urban areas (small rural vs. urban: OR = 1.37, 95% CI 1.07-1.76) were more likely to have DDIs.
CONCLUSION: Demographic and socioeconomic disparities in PIM use and DDIs exist. Future studies should seek to better understand factors contributing to the disparities in order to guide development of interventions.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug-drug interaction; Potentially inappropriate medication; REGARDS; Socioeconomic disparity

Mesh:

Year:  2020        PMID: 32098707      PMCID: PMC7438264          DOI: 10.1016/j.sapharm.2020.02.008

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  35 in total

Review 1.  American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2012-02-29       Impact factor: 5.562

2.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

3.  Are racial disparities in health conditional on socioeconomic status?

Authors:  Melissa M Farmer; Kenneth F Ferraro
Journal:  Soc Sci Med       Date:  2005-01       Impact factor: 4.634

Review 4.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

5.  Time use in clinical encounters: are African-American patients treated differently?

Authors:  M N Oliver; M A Goodwin; R S Gotler; P M Gregory; K C Stange
Journal:  J Natl Med Assoc       Date:  2001-10       Impact factor: 1.798

Review 6.  Implicit Racial/Ethnic Bias Among Health Care Professionals and Its Influence on Health Care Outcomes: A Systematic Review.

Authors:  William J Hall; Mimi V Chapman; Kent M Lee; Yesenia M Merino; Tainayah W Thomas; B Keith Payne; Eugenia Eng; Steven H Day; Tamera Coyne-Beasley
Journal:  Am J Public Health       Date:  2015-10-15       Impact factor: 9.308

Review 7.  Inappropriate prescribing in the elderly.

Authors:  P Gallagher; P Barry; D O'Mahony
Journal:  J Clin Pharm Ther       Date:  2007-04       Impact factor: 2.512

8.  Health literacy not race predicts end-of-life care preferences.

Authors:  Angelo E Volandes; Michael Paasche-Orlow; Muriel R Gillick; E F Cook; Shimon Shaykevich; Elmer D Abbo; Lisa Lehmann
Journal:  J Palliat Med       Date:  2008-06       Impact factor: 2.947

Review 9.  Polypharmacy in elderly patients.

Authors:  Emily R Hajjar; Angela C Cafiero; Joseph T Hanlon
Journal:  Am J Geriatr Pharmacother       Date:  2007-12

10.  Examining the Presence, Consequences, and Reduction of Implicit Bias in Health Care: A Narrative Review.

Authors:  Colin A Zestcott; Irene V Blair; Jeff Stone
Journal:  Group Process Intergroup Relat       Date:  2016-05-08
View more
  2 in total

1.  Racial Disparities in Preventable Adverse Events Attributed to Poor Care Coordination Reported in a National Study of Older US Adults.

Authors:  Laura C Pinheiro; Evgeniya Reshetnyak; Monika M Safford; Lisa M Kern
Journal:  Med Care       Date:  2021-10-01       Impact factor: 3.178

2.  Racial and ethnic disparities associated with the measure for drug-drug interactions among Medicare beneficiaries.

Authors:  Jamie Browning; Chi Chun Steve Tsang; Jim Y Wan; Marie A Chisholm-Burns; Samuel Dagogo-Jack; William C Cushman; Xiaobei Dong; Junling Wang
Journal:  J Am Pharm Assoc (2003)       Date:  2021-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.